Sharp Therapeutics Appoints Co-Founder Of National Gaucher Foundation And Clinical Researcher Robin Ely, M.D., To Advisory Board

PITTSBURGH and TORONTO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Sharp Therapeutics Corp. ("Sharp" or the "Company") (TSX-V: SHRX) (OTCQB: SHRXF), a biotechnology company developing small-molecule therapeutics for genetic diseases, announced today the appointment of Robin Ely, M.D., the Clinical Director and co-founder of the National Gaucher Foundation (NGF), to its Advisory Board. Dr. Ely co-founded NGF in 1984 after her son was diagnosed with Gaucher disease. Dr. Ely played a pivotal role in facilitating the U. ...